Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
12/8/2024
ChipScreen Announces Mixed Phase III Results for Chiauranib in SCLC Tr...
12/8/2024
BioNTech and DualityBio Unveil Promising Interim Results for Partnered...
12/5/2024
SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...
12/5/2024
Cinclus Wins Marketing Approval in China for GERD Drug Linaprazan Glur...
12/5/2024
Abbisko’s PRMT5*MTA Inhibitor ABSK131 Granted IND Clearance from the ...
12/4/2024
Everest Medicines Announces Positive Results in Preliminary Analysis o...
12/3/2024
PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...
12/2/2024
Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...
12/2/2024
Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024
12/2/2024
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the ...
12/2/2024
Everest Medicines Announces Acceptance of VELSIPITY NDA in Hong Kong
11/27/2024
CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
11/27/2024
NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib for Advanced H...
11/27/2024
Hengrui Initiates Clinical Trial for SHR-1826, a c-Met ADC Drug
11/25/2024
China's Real-World Data Pilot Drives Global Collaboration and Regulato...
11/25/2024
Rui Thera Present Clinical Trial Results of CD19 CAR NK Cell Therapy i...
11/25/2024
Zhongsheng Announces Promising Phase II Results for Weight Loss Drug R...
11/21/2024
China Strengthens Focus on Gene and Cell Therapy Research in Suzhou
11/21/2024
Merck's Belzutifan Approved in China for VHL Disease-Associated Tumors
11/20/2024
China-U.S. Health Experts Convene in Beijing to Address Cancer and Chr...
11/19/2024
China Grants Priority Review to Ascentage Pharma's Lisaftoclax NDA
11/18/2024
ITabMed Unveils Promising Clinical Data on BsAb A-319 for Severe Refra...
11/18/2024
FDA Grants BTD to Huahui Health's Libevitug (HH-003) for Chronic HDV I...
11/18/2024
Rona Therapeutics Unveils Promising Phase 1 Results for RNA-Based Chol...
11/18/2024
Merck KGaA and Abbisko's Pimicotinib Shows Promise in Treating Rare Jo...
11/14/2024
Sino Biopharma Gains Chinese Approval for Garsorasib for Advanced NSCL...
11/13/2024
Novartis Files NDA of Pluvicto (Lu 177 vipivotide tetraxetan) in China
11/13/2024
NMPA Accepts CANbridge Pharma's NDA of CAN103 for Gaucher Disease
11/12/2024
Eccogene Secures Dual IND Approvals for Once-Daily Oral GLP-1 Receptor...
11/12/2024
CStone Presents Promising Preclinical Data for Trispecific Antibody CS...
Page:
7
/
11
Total number of articles:
323
:
[First]
[<<]
[5]
[6]
[7]
[8]
[9]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit